ASH 2019 Treatment of Older FCR Ineligible CLL Pts: 5 Years Follow‐up on Ibrutinib, Time Limited Therapies & High Rates of Undetectable MRD With Ibrutinib/Venetoclax

19 views
March 20, 2020
Comments 0
Login to view comments. Click here to Login